{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:28:59Z","timestamp":1786422539001,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07219-4","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:30:32Z","timestamp":1784169032000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of different doses of intravenous immunoglobulin combined with phototherapy in neonatal hemolytic disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"185","author":[{"given":"Meixiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongmei","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"7219_CR1","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/phmt.S327032","volume":"12","author":"AK Myle","year":"2021","unstructured":"Myle AK, Al-Khattabi GH (2021) Hemolytic disease of the newborn: a review of current trends and prospects. Pediatric Health Med Ther 12:491\u20138. https:\/\/doi.org\/10.2147\/phmt.S327032","journal-title":"Pediatric Health Med Ther"},{"key":"7219_CR2","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cll.2020.10.009","volume":"41","author":"ME Jackson","year":"2021","unstructured":"Jackson ME, Baker JM (2021) Hemolytic disease of the fetus and newborn: historical and current state. Clin Lab Med 41:133\u201351. https:\/\/doi.org\/10.1016\/j.cll.2020.10.009","journal-title":"Clin Lab Med"},{"key":"7219_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.26574\/maedica.2024.19.4.711","volume":"19","author":"D Patale","year":"2024","unstructured":"Patale D, Sharma J, Modi C, Bhagwat S (2024) Early prediction of ABO HDN using immuno-hematological and biochemical tests. Maedica 19:711\u20137. https:\/\/doi.org\/10.26574\/maedica.2024.19.4.711","journal-title":"Maedica"},{"key":"7219_CR4","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1038\/s41598-023-28254-3","volume":"13","author":"N Jiang","year":"2023","unstructured":"Jiang N, Qian L, Lin G, Zhang Y, Hong S, Sun B, Wang H, Huang M, Wang J, Jiang Q (2023) Maternal blood parameters and risk of neonatal pathological jaundice: a retrospective study. Sci Rep 13:2627. https:\/\/doi.org\/10.1038\/s41598-023-28254-3","journal-title":"Sci Rep"},{"key":"7219_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1891\/nn-2024-0051","volume":"44","author":"M Falke","year":"2025","unstructured":"Falke M (2025) The basics of neonatal hyperbilirubinemia. Neonatal Netw 44:61\u20137. https:\/\/doi.org\/10.1891\/nn-2024-0051","journal-title":"Neonatal Netw"},{"key":"7219_CR6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-058859","author":"AR Kemper","year":"2022","unstructured":"Kemper AR, Newman TB, Slaughter JL, Maisels MJ, Watchko JF, Downs SM, Grout RW, Bundy DG, Stark AR, Bogen DL et al (2022) Clinical practice guideline revision: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. https:\/\/doi.org\/10.1542\/peds.2022-058859","journal-title":"Pediatrics"},{"key":"7219_CR7","doi-asserted-by":"publisher","unstructured":"(1987). Treatment of immune hemolytic anemia with gammaglobulin. J Pediatr 110, 817\u2013818. https:\/\/doi.org\/10.1016\/s0022-3476(87)80036-7","DOI":"10.1016\/s0022-3476(87)80036-7"},{"key":"7219_CR8","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/s2352-4642(18)30139-1","volume":"2","author":"BO Olusanya","year":"2018","unstructured":"Olusanya BO, Kaplan M, Hansen TWR (2018) Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc Health 2:610\u201320. https:\/\/doi.org\/10.1016\/s2352-4642(18)30139-1","journal-title":"Lancet Child Adolesc Health"},{"issue":"Suppl 5","key":"7219_CR9","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1016\/j.htct.2024.03.002","volume":"46","author":"SZ Jalali","year":"2024","unstructured":"Jalali SZ, Mahdipour S, Asgarzad R, Saadat F (2024) Effect of intravenous immunoglobulin on the management of Rh- and ABO-mediated hemolytic disease of the newborn. Hematol Transfus Cell Ther 46(Suppl 5):S57-s64. https:\/\/doi.org\/10.1016\/j.htct.2024.03.002","journal-title":"Hematol Transfus Cell Ther"},{"key":"7219_CR10","doi-asserted-by":"publisher","first-page":"7701","DOI":"10.1080\/14767058.2021.1960970","volume":"35","author":"R Vidavalur","year":"2022","unstructured":"Vidavalur R, Devapatla S (2022) Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study. J Matern Fetal Neonatal Med 35:7701\u20136. https:\/\/doi.org\/10.1080\/14767058.2021.1960970","journal-title":"J Matern Fetal Neonatal Med"},{"key":"7219_CR11","first-page":"914","volume":"49","author":"S Huang","year":"2020","unstructured":"Huang S, Liu L, Qian G, Liu W, Wang J, Li M, Yang G (2020) The improvement effect of different doses of gamma globulin on the disease condition of infants with hemolytic disease of newborn and their effects on immune factors in serum. Iran J Public Health 49:914\u2013922","journal-title":"Iran J Public Health"},{"key":"7219_CR12","first-page":"653","volume":"45","author":"G Girish","year":"2008","unstructured":"Girish G, Chawla D, Agarwal R, Paul VK, Deorari AK (2008) Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn\u2013a randomized controlled trial. Indian Pediatr 45:653\u20139","journal-title":"Indian Pediatr"},{"key":"7219_CR13","doi-asserted-by":"publisher","first-page":"Cd000361","DOI":"10.1002\/14651858.CD000361.pub4","volume":"1","author":"A Ohlsson","year":"2020","unstructured":"Ohlsson A, Lacy JB (2020) Intravenous immunoglobulin for preventing infection in preterm and\/or low birth weight infants. Cochrane Database Syst Rev 1:Cd000361. https:\/\/doi.org\/10.1002\/14651858.CD000361.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"7219_CR14","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ajog.2021.04.211","volume":"225","author":"JB Bussel","year":"2021","unstructured":"Bussel JB, Vander Haar EL, Berkowitz RL (2021) New developments in fetal and neonatal alloimmune thrombocytopenia. Am J Obstet Gynecol 225:120\u20137. https:\/\/doi.org\/10.1016\/j.ajog.2021.04.211","journal-title":"Am J Obstet Gynecol"},{"key":"7219_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00431-010-1310-8","volume":"170","author":"MS Elalfy","year":"2011","unstructured":"Elalfy MS, Elbarbary NS, Abaza HW (2011) Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn\u2013a prospective randomized controlled trial. Eur J Pediatr 170:461\u20137. https:\/\/doi.org\/10.1007\/s00431-010-1310-8","journal-title":"Eur J Pediatr"},{"key":"7219_CR16","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.7534\/j.issn.1009-2137.2016.06.041","volume":"24","author":"YF Liu","year":"2016","unstructured":"Liu YF, Zou CC, Yang HQ, Lou LJ (2016) Comparison of therapeutic efficacy for neonatal ABO hemolytic disease treated with intravenous immunoglobin G by different modes of administration. Zhongguo shi yan xue ye xue za zhi 24:1842\u20135. https:\/\/doi.org\/10.7534\/j.issn.1009-2137.2016.06.041","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"key":"7219_CR17","unstructured":"Hongmei G (2020) Observation on curative effect of different doses of gamma globulin on neonatal ABO hemolytic disease. Drugs Clinic 17:28\u201330"},{"key":"7219_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.13201\/j.issn.1004-2806.2021.04.013","volume":"34","author":"H Qiang","year":"2021","unstructured":"Qiang H, Hua G, Guang Y (2021) Effect of different doses of gamma globulin combined with phototherapyin treatment of children with ABO hemolysis. J Clin Hematol 34:275. https:\/\/doi.org\/10.13201\/j.issn.1004-2806.2021.04.013","journal-title":"J Clin Hematol"},{"key":"7219_CR19","first-page":"31","volume":"50","author":"J Junhua","year":"2012","unstructured":"Junhua J (2012) Effect of different dose regimes of intravenous of immunoglobulin in treatment of hemolytic disease of newborn. China Mod Doc 50:31\u20132","journal-title":"China Mod Doc"},{"key":"7219_CR20","first-page":"802","volume":"14","author":"W Yungang","year":"2015","unstructured":"Yungang W, Ie LW (2015) Comparison of clinical efficacy of different doses of human gamma globulin intreatment of neonatal hemolysis. J Clin Psychosom Dis 14:802\u20135","journal-title":"J Clin Psychosom Dis"},{"key":"7219_CR21","first-page":"76","volume":"13","author":"T Zb","year":"2023","unstructured":"Zb T (2023) Analysis of the effect of High-dose intravenous human immunoglobulin in the treatment of neonatal ABO hemolytic disease. Front Med 13:76\u20138","journal-title":"Front Med"},{"key":"7219_CR22","unstructured":"JH Y, L D, XY Y, HY L (2019) Observation on the clinical effects of high-dose and low-dose gamma globulin (IVIG) treatment in neonatal ABO hemolytic disease. Home Med 53\u20134"},{"key":"7219_CR23","doi-asserted-by":"publisher","unstructured":"G X (2019) Analysis of the clinical effect of early high-dose gamma globulin in the treatment of neonatal ABO hemolytic disease. *Guide of China Medicine Analysis of the clinical effect of early high-dose gamma globulin in the treatment of neonatal ABO hemolytic disease*. 17:134\u20135. https:\/\/doi.org\/10.15912\/j.cnki.gocm.2019.15.097","DOI":"10.15912\/j.cnki.gocm.2019.15.097"},{"key":"7219_CR24","doi-asserted-by":"publisher","unstructured":"(2025) Guidelines for the diagnosis and treatment of common neonatal diseases in primary healthcare institutions: neonatal jaundice (2025). Zhongguo dang dai er ke za zhi. 27:1433\u201343. https:\/\/doi.org\/10.7499\/j.issn.1008-8830.2505012","DOI":"10.7499\/j.issn.1008-8830.2505012"},{"key":"7219_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/bjh.18170","volume":"198","author":"L Lieberman","year":"2022","unstructured":"Lieberman L, Lopriore E, Baker JM, Bercovitz RS, Christensen RD, Crighton G, Delaney M, Goel R, Hendrickson JE, Keir A et al (2022) International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn. Brit J Haematol 198:183\u201395. https:\/\/doi.org\/10.1111\/bjh.18170","journal-title":"Brit J Haematol"},{"key":"7219_CR26","doi-asserted-by":"publisher","first-page":"102646","DOI":"10.1016\/j.bpobgyn.2025.102646","volume":"102","author":"H Malik","year":"2025","unstructured":"Malik H, Verweij E, Mustafa HJ (2025) Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol 102:102646. https:\/\/doi.org\/10.1016\/j.bpobgyn.2025.102646","journal-title":"Best Pract Res Clin Obstet Gynaecol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07219-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07219-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07219-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:49:49Z","timestamp":1786420189000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07219-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7219"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07219-4","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"25 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"580"}}